*** Thursday November 5, 2020 at 8am PT | 11am ET *** It’s time to take your commercial forecast “glocal”! Eliminate the barriers to getting the best of both local- and global-level data sources and expertise. ***On demand available after final airing until Nov. 5, 2021***
***Live: Wednesday, Oct. 7, 2020 at 10am EDT*** Integrating natural history of disease studies into the early clinical development planning process can accelerate drug development, improve the odds of regulatory approval and reimbursement, and bring new life-changing treatments to patients. Join the upcoming webinar to discover more. *** On demand available after final airing until Oct. 7, 2021.***
Innovation in oncology care is rapidly evolving with advances in personalized medicine and biomarker testing that have the potential to lead to better patient outcomes. However, barriers for optimal adoption, particularly with biomarker testing, still exist. Explore these barriers and discover approaches to overcome them. Live: Tuesday, Sept. 29, 2020 at 10am EDT On demand available after airing until Sep. 29, 2021
As uncertainty and shifting market dynamics are disrupting the way pharma does commercial forecasting, forecasting teams are making big changes to reduce manual complexity, decrease cycle time and broaden the visibility of forecasts. Together, these steps allow best-in-class pharmaceutical organizations to meet rapid change with more confidence. Live: Wednesday, Sep. 2, 2020 at 11am EDT On demand available after airing until Sep. 2, 2021 Register free
Healthcare decision-makers have become increasingly aware of the need to utilize real world data (RWD) to better-understand treatment patterns, disease burden, and the impact of interventions from both a clinical and cost perspective. Join IQVIA to learn more about the pivotal role RWD now plays in informing decisions about access and reimbursement, drug safety, and comparative effectiveness. Live: Thursday, Aug. 20, 2020 at 2pm EDT On demand available after airing until Aug. 20, 2021.
The pool of available Real World Data sources for Pharma is both impressive and expanding continuously, but how do you determine the credibility of those sources? Join us as we share tools and strategies to identify the right data source for your organization, and improve both the quality and impact of your Real World Evidence studies. Live: Tuesday, Jul. 28, 2020 at 11am EDT On demand available after airing until Jul. 28, 2021 Register free
What patient support looks like when there are potential challenges to care continuity – a COVID-19 perspective from IQVIA. Live: Tuesday, Jun. 30, 2020 | 11am EDT On demand available after airing until Jun. 30, 2021. Register free
Join this virtual event to better understand the role and importance of RWE during and after COVID-19, what it means for your business today, and how you can plan for tomorrow with confidence. Live: Thursday, Jun. 25, 2020 at 7:00am EDT – 2:00pm EDT | 13:00 CET – 20:00 CET On demand available after airing until Jun. 25, 2021. Register free
How can an ocean of real-world pharmaceutical data help build better commercial forecasts? Join us to understand how big data can create forecasts with unprecedented fidelity and accuracy. Live: Wednesday, Jun. 24, 2020 at 11am EDT On demand available after airing until Jun. 24, 2021. Register free
Would you like to understand how pharma companies can use AI to increase new patient starts by 20% in just three months? Learn how machine learning could make all the difference for your brand, helping your sales force engage HCPs with precision, confidence and impact. Live: Thursday, Jun. 18, 2020 at 11am EDT On demand available after airing until Jun. 18, 2021. Register free
How routinely collected healthcare data can accelerate your real world evidence generation plan efficiently while minimizing burden on sites and patients. During this session you will have the opportunity to learn how secondary data can help address questions asked by different healthcare stakeholders and demonstrate safety, value, and effectiveness of your compound. Live: US: Wednesday, Jun. 10, 2020 10am EDT | 4pm CEST On demand available after airing until Jun. 10, 2021. Register free
What market access looks like now and what’s next – a COVID-19 perspective from IQVIA. Live: Thursday, May 28, 2020, 2020 at 11am EDT On demand available after airing until May 28, 2021. Register free
Learn how the diabetes management space is evolving with new metrics such as Time In Range (TIR), time below range (TBR) and time above range (TAR) growing prominence and the potential benefits that can be achieved by improvements in these metrics Live: Thursday, Mar. 26, 2020 at 11am EDT | 10am PDT | 4pm BST | 5pm CEST On demand available after airing until Mar. 26, 2021. Register free
This webinar will provide an overview of the Japanese regulations and development in the Japanese market. Live: Thursday, Oct. 31, 2019 at 11am EDT On demand available after airing until Oct. 31, 2020 Register free
Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. A genetic screening project, LC-SCRUM, conducted by the National Cancer Center, is contributing to the development of multiple novel therapeutics in Japan. Live: Tuesday, Oct. 29, 2019 at 11am JST On demand available after airing until Oct. 29, 2020 Register free
Japan, the second largest market for branded pharmaceuticals and innovation, is driven in part by Oncology with recent advances in genomic analysis technology. A genetic screening project, LC-SCRUM, conducted by the National Cancer Center, is contributing to the development of multiple novel therapeutics in Japan. Live: Tuesday, Oct.15, 2019 at 5pm JST and Tuesday, Oct. 29, 2019 at 11am JST On demand available after airing until Oct.15, 2020 and Oct. 29, 2020 Register free
